Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
testosterone enanthate androgen receptor small molecule NA drugbank , DGIDB Systemic arterial pressure[MeSHID:D062186]
Sexual Development[MeSHID:D046468]
Neoplasms[MeSHID:D009369]
Pituitary Gland[MeSHID:D010902]
Klinefelter Syndrome[MeSHID:D007713]
Myocardial Infarction[MeSHID:D009203]
Syndrome[MeSHID:D013577]
Pituitary Diseases[MeSHID:D010900]
Idiopathic hypogonadotropic hypogonadism[MeSHID:C562785]
Mammary gland[MeSHID:D042361]
Testicular hypogonadism[MeSHID:D005058]
Thyroid Gland[MeSHID:D013961]
Testis[MeSHID:D013737]
Orchitis[MeSHID:D009920]
Neoplasm Metastasis[MeSHID:D009362]
Cryptorchidism[MeSHID:D003456]
Hypothalamic structure[MeSHID:D007031]
Malignant neoplasm of breast[MeSHID:D001943]
Cerebrovascular accident[MeSHID:D020521]
Electromagnetic Radiation[MeSHID:D060733]
Breast[MeSHID:D001940]
Radiation[MeSHID:D011827]
Cessation of life[MeSHID:D003643]
Blood Pressure[MeSHID:D001794]
Maintenance[MeSHID:D008283]
Pathologic Processes[MeSHID:D010335]
Primary hypogonadism[MeSHID:D007006]
Malnutrition[MeSHID:D044342]
Adrenal Cortex[MeSHID:D000302]
Disease[MeSHID:D004194]
Delayed Puberty[MeSHID:D011628]
Traumatic injury[MeSHID:D014947]
Malignant Carcinoid Syndrome[MeSHID:D008303]		 0.07 approved agonist
testosterone enanthate estrogen receptor alpha small molecule NA drugbank Systemic arterial pressure[MeSHID:D062186]
Sexual Development[MeSHID:D046468]
Neoplasms[MeSHID:D009369]
Pituitary Gland[MeSHID:D010902]
Klinefelter Syndrome[MeSHID:D007713]
Myocardial Infarction[MeSHID:D009203]
Syndrome[MeSHID:D013577]
Pituitary Diseases[MeSHID:D010900]
Idiopathic hypogonadotropic hypogonadism[MeSHID:C562785]
Mammary gland[MeSHID:D042361]
Testicular hypogonadism[MeSHID:D005058]
Thyroid Gland[MeSHID:D013961]
Testis[MeSHID:D013737]
Orchitis[MeSHID:D009920]
Neoplasm Metastasis[MeSHID:D009362]
Cryptorchidism[MeSHID:D003456]
Hypothalamic structure[MeSHID:D007031]
Malignant neoplasm of breast[MeSHID:D001943]
Cerebrovascular accident[MeSHID:D020521]
Electromagnetic Radiation[MeSHID:D060733]
Breast[MeSHID:D001940]
Radiation[MeSHID:D011827]
Cessation of life[MeSHID:D003643]
Blood Pressure[MeSHID:D001794]
Maintenance[MeSHID:D008283]
Pathologic Processes[MeSHID:D010335]
Primary hypogonadism[MeSHID:D007006]
Malnutrition[MeSHID:D044342]
Adrenal Cortex[MeSHID:D000302]
Disease[MeSHID:D004194]
Delayed Puberty[MeSHID:D011628]
Traumatic injury[MeSHID:D014947]
Malignant Carcinoid Syndrome[MeSHID:D008303]		 NA approved unknown
testosterone enanthate mineralocorticoid receptor small molecule NA drugbank Systemic arterial pressure[MeSHID:D062186]
Sexual Development[MeSHID:D046468]
Neoplasms[MeSHID:D009369]
Pituitary Gland[MeSHID:D010902]
Klinefelter Syndrome[MeSHID:D007713]
Myocardial Infarction[MeSHID:D009203]
Syndrome[MeSHID:D013577]
Pituitary Diseases[MeSHID:D010900]
Idiopathic hypogonadotropic hypogonadism[MeSHID:C562785]
Mammary gland[MeSHID:D042361]
Testicular hypogonadism[MeSHID:D005058]
Thyroid Gland[MeSHID:D013961]
Testis[MeSHID:D013737]
Orchitis[MeSHID:D009920]
Neoplasm Metastasis[MeSHID:D009362]
Cryptorchidism[MeSHID:D003456]
Hypothalamic structure[MeSHID:D007031]
Malignant neoplasm of breast[MeSHID:D001943]
Cerebrovascular accident[MeSHID:D020521]
Electromagnetic Radiation[MeSHID:D060733]
Breast[MeSHID:D001940]
Radiation[MeSHID:D011827]
Cessation of life[MeSHID:D003643]
Blood Pressure[MeSHID:D001794]
Maintenance[MeSHID:D008283]
Pathologic Processes[MeSHID:D010335]
Primary hypogonadism[MeSHID:D007006]
Malnutrition[MeSHID:D044342]
Adrenal Cortex[MeSHID:D000302]
Disease[MeSHID:D004194]
Delayed Puberty[MeSHID:D011628]
Traumatic injury[MeSHID:D014947]
Malignant Carcinoid Syndrome[MeSHID:D008303]		 NA approved unknown
click here to return to the previous page